531

mRNA vaccines and treatments

To develop and maintain Australia's onshore capability to manufacture mRNA products, as a measure to give effect to Australia's obligations under the International Covenant on Economic, Social and Cultural Rights, particularly Articles 2 and 12.

This objective also has the effect it would have if it were limited to measures:

(a) for the provision of, or incidental to the provision of, pharmaceutical, sickness or hospital benefits or medical services (within the meaning of paragraph 51(xxiiiA) of the Constitution); or

(b) that are peculiarly adapted to the government of a nation and cannot otherwise be carried on for the benefit of the nation.